DE60041889D1 - In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln - Google Patents

In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln

Info

Publication number
DE60041889D1
DE60041889D1 DE60041889T DE60041889T DE60041889D1 DE 60041889 D1 DE60041889 D1 DE 60041889D1 DE 60041889 T DE60041889 T DE 60041889T DE 60041889 T DE60041889 T DE 60041889T DE 60041889 D1 DE60041889 D1 DE 60041889D1
Authority
DE
Germany
Prior art keywords
vlps
papilloma
particulars
disappearance
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60041889T
Other languages
English (en)
Inventor
Michael P Mccarthy
Joanne A Suzich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/457,594 external-priority patent/US6962777B1/en
Application filed by MedImmune LLC filed Critical MedImmune LLC
Application granted granted Critical
Publication of DE60041889D1 publication Critical patent/DE60041889D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60041889T 1999-12-09 2000-12-08 In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln Expired - Lifetime DE60041889D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/457,594 US6962777B1 (en) 1997-09-05 1999-12-09 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
PCT/US2000/033317 WO2001042780A1 (en) 1999-12-09 2000-12-08 IN VITRO METHOD FOR DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE PARTICLES (VLPs)

Publications (1)

Publication Number Publication Date
DE60041889D1 true DE60041889D1 (de) 2009-05-07

Family

ID=23817343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60041889T Expired - Lifetime DE60041889D1 (de) 1999-12-09 2000-12-08 In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln

Country Status (7)

Country Link
EP (1) EP1250593B1 (de)
AT (1) ATE426803T1 (de)
AU (1) AU1955001A (de)
CA (2) CA2875298A1 (de)
DE (1) DE60041889D1 (de)
ES (1) ES2325053T3 (de)
WO (1) WO2001042780A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1314738A1 (de) * 2001-08-23 2003-05-28 Virofem Diagnostika GmbH Pseudovirionen, die Viruscapside, Histone und Nukleinsäuren enthalten als Arzneimittel
DE10237639A1 (de) * 2002-08-13 2004-02-26 Martin-Luther-Universität Halle-Wittenberg Verfahren zur Herstellung von virusanalogen Partikeln durch in vitro-Assemblierung von Kapsomeren oder von Kapsomeren, an die biologisch aktive Makromoleküle gebunden sind, bei gleichzeitiger Verpackung der Makromoleküle
ITMI20030175A1 (it) * 2003-02-04 2004-08-05 Giorgio Conti Uso del 2-mercaptoetansolfonato di sodio come agente antivirale
EP1785433A4 (de) 2004-07-01 2008-10-01 Tokyo Inst Tech Viruspartikelähnliches konstrukt und verfahren zu dessen bildung unter physiologischen bedingungen
GB0820822D0 (en) 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749323B1 (fr) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique
ES2572628T3 (es) * 1997-09-05 2016-06-01 Medimmune, Inc. Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP)
FR2768749A1 (fr) * 1997-09-22 1999-03-26 Inst Nat Sante Rech Med Virus artificiels derives de papillomavirus, et leurs utilisations, notamment en therapie genique
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
US6245568B1 (en) * 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles

Also Published As

Publication number Publication date
WO2001042780A1 (en) 2001-06-14
EP1250593B1 (de) 2009-03-25
ATE426803T1 (de) 2009-04-15
CA2875298A1 (en) 2001-06-14
EP1250593A1 (de) 2002-10-23
CA2394052C (en) 2015-03-17
AU1955001A (en) 2001-06-18
CA2394052A1 (en) 2001-06-14
EP1250593A4 (de) 2004-03-31
ES2325053T3 (es) 2009-08-25

Similar Documents

Publication Publication Date Title
CY1107987T1 (el) In vitro μεθοδος αποσυγκροτησης/επανασυγκροτησης σωματιδιων που μοιαζουν με ιο θηλωματος (vlp)
HUP0301600A2 (hu) Humán köldökzsinórvér-eredetű nem korlátozott szomatikus őssejtek (USSC)
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
WO2003001982A3 (en) Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ
CA2523032A1 (en) Vaccines for cancer therapy
NZ602824A (en) Sparc binding peptides and uses thereof
TW200712208A (en) Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
DE69916504D1 (de) Zyklodexrinpolymere zum gebrauch als medikamententräger
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
TW200518753A (en) Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
HK1044484A1 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide.
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
HK1068913A1 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
IL206830A (en) Use of an integrin-containing antagonist of the alpha 1 subunit - of the integrin to prepare a drug for the treatment of osteoporosis
WO2002086073A3 (en) Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
DE60033649D1 (de) Verbindungen und therapeutische methoden
DE50001995D1 (de) Verfahren zur verschönerung der form des menschlichen körpers mittels eines kosmetikpflasters
BR0211604A (pt) Inibidores de integrina para o tratamento de doenças do olho
DE60041889D1 (de) In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln
ATE316980T1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
CA2442284A1 (en) Biodegradable carrier and method for preparation thereof
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MEDIMMUNE, LLC, GAITHERSBURG, MD., US

8364 No opposition during term of opposition